$CBIS a U.S. company specializing in the development of cannabinoid-based medicines, recently announced a pending offering memorandum for expansion capital, another large drug development deal, and an expedited seeding schedule, all of which are expected to create sustainable equity value and unprecedented revenue growth for the company.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!